HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases

Keralty is an international integrated health group with over 6.9 million patients and 24,450 professionals across Colombia, Peru, Mexico, and the United States. Our organisation combines healthcare delivery, diagnostics, digital health, and research, with extensive experience in H2020 and Horizon Europe projects.

Keralty is well positioned to contribute to HORIZON-HLTH-2027-02-DISEASE-01, supporting implementation research to tackle chronic non-communicable diseases (NCDs) through healthcare interventions beyond traditional healthcare settings. Our key capabilities include:

• Conducting clinical studies to evaluate interventions in diverse populations, including underserved communities and LMICs

• Leveraging a network of over 70 laboratories staffed with highly qualified professionals and equipped with cutting-edge technology in genomics, infectious diseases, and molecular diagnostics

• Integrating digital tools, AI-driven analysis, and real-world data to monitor, evaluate, and optimise interventions across sectors such as education, workplace, community, and urban environments

• Developing evidence-based strategies for prevention, management, and control of NCDs, tailored to the cultural, social, and economic contexts of target populations

In addition, BioKeralty Research Institute, part of Keralty’s R&D&I division, can provide complementary support in data analysis, methodology development, FAIR data management, and dissemination, as well as stakeholder engagement strategies to ensure sustainable implementation. BioKeralty also contributes expertise in health systems innovation, implementation science, and translational research, supporting projects that aim to improve population health outcomes and equitable access to care.

Together, Keralty and BioKeralty offer a strong combination of clinical trial capability, laboratory infrastructure, implementation research experience, and EU project expertise, making them ideal partners for projects aiming to implement and scale multisectoral interventions for NCDs, engaging healthcare and non-healthcare sectors to maximize health outcomes, equity, and long-term sustainability.